Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
NCT ID: NCT00033020
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
390 participants
INTERVENTIONAL
2001-04-30
2003-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incentives to Decrease Opioid Use - Pilot
NCT04235582
Comparison of Two Counseling Induction Strategies
NCT01141920
Mindfulness-Based Relapse Prevention for Methadone Maintenance
NCT03882125
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavior Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment
Exclusion Criteria
2. Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johns Hopkins Bayview Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxine Stitzer, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aegis Medical Systems, Inc.
Bakersfield, California, United States
Oasis Clinic
Washington D.C., District of Columbia, United States
Glenwood Life Counseling Center
Baltimore, Maryland, United States
Lower Eastside Service Center (LESC)
New York, New York, United States
Greenwich House, Inc.
New York, New York, United States
ACT
Philadelphia, Pennsylvania, United States
Charleston Center
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTN-0007-1
Identifier Type: -
Identifier Source: org_study_id
NCT00015418
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.